Man Group’s 2seventy bio TSVT Stock Holding History

Man Group’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,043,026	Closed	-$10.1M	–	2392
2025 Q1	$10.1M	Buy	+2,043,026	New	+$6.49M	0.03%	726
2023 Q1	–	Sell	-79,504	Closed	-$745K	–	2256
2022 Q4	$745K	Buy	+79,504	New	+$1.12M	﹤0.01%	1404
2022 Q2	–	Hold	0	–	–	–	1842

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Man Group's TSVT Position: Q2 2025 in Review

Man Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 2,043,026 shares — an estimated $10.1M sold.

Man Group first reported a position in TSVT in Q4 2022 and held it in 2 quarters. The position peaked at $10.1M in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Man Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Man Group sold 2,043,026 2seventy bio shares in Q2 2025, an estimated $10.1M.
Man Group first reported a position in 2seventy bio in Q4 2022 and held it in 2 quarters.
Man Group's 2seventy bio position peaked at $10.1M in Q1 2025.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.